Gao Yuan, Liu Ji, Wang Wanjun, Gao Chunlin, Yu Changshen, Liu Shoufeng, Wu Jialing
Department of Neurology and Neurorehabilitation, Tianjin Huanhu Hospital, Tianjin Key Laboratory of Cerebrovascular and Neurodegenerative Diseases, Tianjin, China.
Eur Neurol. 2017;78(1-2):48-55. doi: 10.1159/000477929. Epub 2017 Jun 17.
High-sensitivity C-reactive protein (hs-CRP) is associated with a risk of causing diabetes mellitus and ischemic stroke. However, the association between hs-CRP levels and functional outcome after small-artery occlusion (SAO) is unknown.
Data for 836 patients diagnosed with SAO were collected from the Department of Neurorehabilitation of Huanhu Hospital. Hs-CRP values were classified according to quartiles (<0.67, 0.67 to <1.46, 1.46 to <3.46, and ≥3.46 mg/L). We examined the relationship between hs-CRP levels on admission and modified Rankin Scale (mRS) scores using univariate and multivariate analyses. We further performed subgroup analyses of patients with and without diabetes.
Patients in the highest hs-CRP quartile had a significantly higher risk of an unfavorable outcome. In the non-diabetes subgroup, the elevated hs-CRP quartiles were associated with higher mRS scores. In the diabetes subgroup, no statistically significant association was observed between hs-CRP levels and mRS.
Elevated hs-CRP level on admission was associated with a poor functional outcome 3 months after SAO, especially among nondiabetes patients. However, no significant associations were observed in patients with diabetes.
高敏C反应蛋白(hs-CRP)与患糖尿病和缺血性中风的风险相关。然而,hs-CRP水平与小动脉闭塞(SAO)后功能结局之间的关联尚不清楚。
从环湖医院神经康复科收集了836例诊断为SAO的患者的数据。hs-CRP值根据四分位数进行分类(<0.67、0.67至<1.46、1.46至<3.46以及≥3.46mg/L)。我们使用单因素和多因素分析研究了入院时hs-CRP水平与改良Rankin量表(mRS)评分之间的关系。我们进一步对有糖尿病和无糖尿病的患者进行了亚组分析。
hs-CRP四分位数最高的患者出现不良结局的风险显著更高。在非糖尿病亚组中,hs-CRP四分位数升高与更高的mRS评分相关。在糖尿病亚组中,未观察到hs-CRP水平与mRS之间存在统计学显著关联。
入院时hs-CRP水平升高与SAO后3个月功能结局不良相关,尤其是在非糖尿病患者中。然而,在糖尿病患者中未观察到显著关联。